
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The current understanding of the immune landscape relative to radiotherapy across tumor types
Chrysanthi Iliadi, Laurine Verset, Christelle Bouchart, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Chrysanthi Iliadi, Laurine Verset, Christelle Bouchart, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Showing 11 citing articles:
Myeloid-derived suppressor cells in cancer and cancer therapy
Samantha Lasser, Feyza Gül Özbay Kurt, Ihor Arkhypov, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 2, pp. 147-164
Closed Access | Times Cited: 132
Samantha Lasser, Feyza Gül Özbay Kurt, Ihor Arkhypov, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 2, pp. 147-164
Closed Access | Times Cited: 132
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 12
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 12
Neoadjuvant chemoradiotherapy combined with sequential perioperative toripalimab in locally advanced esophageal squamous cell cancer
Xin Xu, Zhiyong Sun, Qiang Liu, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 3, pp. e008631-e008631
Open Access | Times Cited: 12
Xin Xu, Zhiyong Sun, Qiang Liu, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 3, pp. e008631-e008631
Open Access | Times Cited: 12
Navigating the Immune Maze: Pioneering Strategies for Unshackling Cancer Immunotherapy Resistance
Liqin Yao, Qingqing Wang, Wenxue Ma
Cancers (2023) Vol. 15, Iss. 24, pp. 5857-5857
Open Access | Times Cited: 13
Liqin Yao, Qingqing Wang, Wenxue Ma
Cancers (2023) Vol. 15, Iss. 24, pp. 5857-5857
Open Access | Times Cited: 13
Unveiling the Inflammatory Landscape of Recurrent Glioblastoma through Histological-Based Assessments
Nicholas B. Dadario, Deborah Boyett, Damian E. Teasley, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3283-3283
Open Access | Times Cited: 3
Nicholas B. Dadario, Deborah Boyett, Damian E. Teasley, et al.
Cancers (2024) Vol. 16, Iss. 19, pp. 3283-3283
Open Access | Times Cited: 3
Immunotherapy for HPV negative head and neck squamous cell carcinoma
Binyumeng Jiang, Ahmed Elkashif, Jonathan A. Coulter, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189138-189138
Open Access | Times Cited: 1
Binyumeng Jiang, Ahmed Elkashif, Jonathan A. Coulter, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189138-189138
Open Access | Times Cited: 1
Adoptive In Situ Vaccination with Cyclical Intermittent Stereotactic Body Radiotherapy (SBRT) and Immunotherapy – a Review and Proposed Strategy
Kumara Swamy
(2023)
Open Access | Times Cited: 3
Kumara Swamy
(2023)
Open Access | Times Cited: 3
GWAS-identified telomere length associated genetic variants predict risk of recurrence of HPV-positive oropharyngeal cancer after definitive radiotherapy
Peng Sun, Peng Wei, Hongliang Liu, et al.
EBioMedicine (2023) Vol. 94, pp. 104722-104722
Open Access | Times Cited: 1
Peng Sun, Peng Wei, Hongliang Liu, et al.
EBioMedicine (2023) Vol. 94, pp. 104722-104722
Open Access | Times Cited: 1
Adoptive In Situ Vaccination with Cyclical Intermittent Stereotactic Body Radiotherapy (SBRT) and Immunotherapy – a Review and Proposed Strategy
Kumara Swamy
(2023)
Open Access | Times Cited: 1
Kumara Swamy
(2023)
Open Access | Times Cited: 1
Navigating the Immune Maze: Pioneering Strategies for Un-shackling Cancer Immunotherapy Resistance
Liqin Yao, Qingqing Wang, Wenxue Ma
(2023)
Open Access | Times Cited: 1
Liqin Yao, Qingqing Wang, Wenxue Ma
(2023)
Open Access | Times Cited: 1
Therapeutic In Situ Cancer Vaccine Using Pulsed Stereotactic Body Radiotherapy—A Translational Model
Kumara Swamy
Vaccines (2023) Vol. 12, Iss. 1, pp. 7-7
Open Access | Times Cited: 1
Kumara Swamy
Vaccines (2023) Vol. 12, Iss. 1, pp. 7-7
Open Access | Times Cited: 1